Grow Everything Podcast – At The Bleeding Edge
Grow Everything Podcast – At The Bleeding Edge Read More »
News
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
Revolutionary hemostatic gel for veterinary surgeons available in U.K. and across Europe through Veterinary Instrumentation and distribution partners NEW YORK (May 20, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary hemostatic gel, VETIGEL®, to be sold
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus Read More »
Cresilon Named Most Innovative Company of the Year
Award recognizes Cresilon’s advancements in bringing its groundbreaking hemostatic technology to human and animal health markets NEW YORK (May 06, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it was named the winner of a Gold Stevie® Award in the Most Innovative Company of the
Cresilon Named Most Innovative Company of the Year Read More »
VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services
Cresilon expands nationwide reach for VETIGEL through distribution agreements with Midwest Veterinary Supply, Victor Medical Company, and Penn Veterinary Supply NEW YORK (April 24, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors
Cresilon Announces Distribution Partnerships for VETIGEL with Leading Animal Health and Veterinary Product Suppliers
Revolutionary hemostatic gel for veterinary surgeons now available through Covetrus, MWI Animal Health, and Patterson Veterinary Supply NEW YORK (April 19, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for its revolutionary hemostatic gel, VETIGEL®, to be sold directly
This company’s hummus-colored gel could change how doctors stop bleeding
Original news piece from Fast Company Cresilon’s hemostatic gel that can help blood clot without pressure has made it one of the most innovative medical device companies of 2024. Every year, about 1.5 million people worldwide die from blood loss. The problem is especially acute when the loss is caused by trauma, which has no
This company’s hummus-colored gel could change how doctors stop bleeding Read More »
Cresilon Launches “VETIGEL Gives” to Sponsor Life-Saving Surgeries for Animals in Need
Cresilon Launches “VETIGEL Gives” to Sponsor Life-Saving Surgeries for Animals in Need Company behind groundbreaking hemostatic technology launches animal philanthropy program at a time when nearly 30% of U.S. pet owners experience barriers to veterinary care NEW YORK (March 13, 2024) — Cresilon Inc. (“Cresilon”), Brooklyn-based biotechnology company focused on hemostatic medical device
Cresilon Launches “VETIGEL Gives” to Sponsor Life-Saving Surgeries for Animals in Need Read More »
Cresilon Announces Distribution Agreement for VETIGEL with Penn Veterinary Supply
Revolutionary hemostatic gel for veterinarians now available through Penn Vet NEW YORK (August 22, 2023) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinarians through Penn Veterinary Supply, an
Cresilon Announces Distribution Agreement for VETIGEL with Penn Veterinary Supply Read More »
